Macrogenics
Clinical trials sponsored by Macrogenics, explained in plain language.
-
New drug MGC028 enters first human tests for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called MGC028 in adults with advanced solid tumors (lung, bile duct, pancreas, or colon cancers) that have not responded to standard treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors or stop the…
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Apr 29, 2026 04:28 UTC
-
New drug MGD024 targets tough blood cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called MGD024 in adults with certain blood cancers (like leukemia and lymphoma) that have not improved with standard treatments or have returned. The main goals are to find a safe dose and understand side effects. About 130 participants wil…
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC